Which indicators should be tracked to analyze pharmaceutical CMO/CDMO outsourcing?
Key indicators to track include available production capacity, site utilization rates, outsourcing contracts, development services, industrial transfer timelines, manufacturing costs, regulatory requirements, dosage-form specialization, quality, GMP compliance and supply chain resilience. These data points help assess CMO/CDMO attractiveness, operational risks and partnership opportunities for pharmaceutical companies and biotechs.